SCHEMBL21611997

SCHEMBL21611997

ClCc1ccn(-c2ccc(Cl)cc2)n1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
NOTUM Q6P988 4/20 0.44
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
KCNH2 Q12809 9/20 0.42
SIGMAR1 Q99720 1/20 0.40
F2 P00734 1/20 0.40
PKM P14618 2/20 0.39
LMNA P02545 1/20 0.39
P2RX7 Q99572 1/20 0.37
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16322113 0.85 NOTUM (0.59) ALDH1A1CYP1A2CYP3A4NOTUMKDM4E
SCHEMBL294640 0.83 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP3A4NOTUMKDM4E
SCHEMBL22111911 0.83 ALDH1A1 (0.48) ALDH1A1CYP1A2CYP3A4NOTUMKDM4E
SCHEMBL14438049 0.83 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP3A4NOTUMKDM4E
SCHEMBL30971440 0.83 KMT2A (0.45) CYP3A4NOTUMKDM4EMAPTKMT2A
SCHEMBL16322298 0.83 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP3A4NOTUMKDM4E
SCHEMBL31274061 0.81 MAOA (0.40) CYP3A4
SCHEMBL31587119 0.80 KCNH2 (0.47) KCNH2SIGMAR1KMT2A
SCHEMBL17887354 0.79 MAPT (0.44) ALDH1A1CYP1A2CYP3A4NOTUMKDM4E
SCHEMBL31273314 0.79 NOTUM (0.45) ALDH1A1NOTUMKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11883387-B2 PqsR inverse agonists Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2024-01-30 US disclosed
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 US disclosed
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 US disclosed
EP-3818045-A1 PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-05-12 EP disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 WO disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11883387-B2 PqsR inverse agonists QRFPR, P2RY11, QARS1 ALDH1A1 4593/4885CYP1A2 2421/4885CYP3A4 3080/4885
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 ALDH1A1 4593/4885CYP1A2 2421/4885CYP3A4 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.